Literature DB >> 7744056

In Chinese hamster ovary K1 cells dog and human thyrotropin receptors activate both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate cascades in the presence of thyrotropin and the cyclic AMP cascade in its absence.

J Van Sande1, S Swillens, C Gerard, A Allgeier, C Massart, G Vassart, J E Dumont.   

Abstract

Thyrotropic hormone, through its human thyrotropin receptor, activates both the cyclic AMP and the phosphatidylinositol 4,5-bisphosphate-phospholipase-C cascades in human thyroid cells and in Chinese hamster ovary cells (CHO-K1) expressing this receptor. However, thyrotropin only activates the cyclic-AMP cascade in dog thyroid cells. In order to establish whether this different pattern of responses reflects a different structure of the human and dog thyrotropin receptors, CHO-K1 cells were permanently transfected with a plasmid coding for one or the other receptor. For various levels of receptor expression, CHO-K1 cells expressing either receptor presented qualitatively similar cyclic AMP and inositol phosphates responses to thyrotropin. This suggests that the difference in the response of the dog and human thyroid to thyrotropin involves elements of the phosphatidylinositol 4,5-bisphosphate cascade downstream of the receptor. In CHO-K1 cells overexpressing the thyrotropin receptor, the basal level of cyclic AMP was raised, suggesting a constitutive activity of the wild-type receptor. This was confirmed in COS-7 cells transiently expressing the human or dog thyrotropin receptors, the basal cyclic AMP levels of these cells increased in parallel with thyrotropin binding. This spontaneous activity of the thyrotropin receptor may have physiological and pathological consequences.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7744056

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.

Authors:  Chun-Rong Chen; Sandra M McLachlan; Paul A Hubbard; Randall McNally; Ramachandran Murali; Basil Rapoport
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

Review 2.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.

Authors:  Sandra M McLachlan; Basil Rapoport
Journal:  Thyroid       Date:  2013-01       Impact factor: 6.568

3.  Central hypothyroidism in a patient with pituitary autoimmunity: evidence for TSH-independent thyroid hormone synthesis.

Authors:  Giuseppe Barbesino; Patrick M Sluss; Patrizio Caturegli
Journal:  J Clin Endocrinol Metab       Date:  2011-11-16       Impact factor: 5.958

4.  Autoantibody mimicry of hormone action at the thyrotropin receptor.

Authors:  Bryan Faust; Christian B Billesbølle; Carl-Mikael Suomivuori; Isha Singh; Kaihua Zhang; Nicholas Hoppe; Antonio F M Pinto; Jolene K Diedrich; Yagmur Muftuoglu; Mariusz W Szkudlinski; Alan Saghatelian; Ron O Dror; Yifan Cheng; Aashish Manglik
Journal:  Nature       Date:  2022-08-08       Impact factor: 69.504

5.  The DREAM protein is associated with thyroid enlargement and nodular development.

Authors:  Marcos Rivas; Britt Mellström; Begoña Torres; Gaetano Cali; Alfonso M Ferrara; Daniela Terracciano; Mariastella Zannini; Gabriella Morreale de Escobar; Jose R Naranjo
Journal:  Mol Endocrinol       Date:  2009-03-19

6.  Thyroid-stimulating hormone rapidly stimulates inositol polyphosphate formation in FRTL-5 thyrocytes without activating phosphoinositidase C.

Authors:  J Singh; P Hunt; M C Eggo; M C Sheppard; C J Kirk; R H Michell
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

Review 7.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

Review 8.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-01-22       Impact factor: 19.871

9.  Regulated and constitutive activation of specific signalling pathways by the human S1P5 receptor.

Authors:  Anke Niedernberg; Andree Blaukat; Torsten Schöneberg; Evi Kostenis
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

10.  Expression Profiling, Downstream Signaling, and Inter-subunit Interactions of GPA2/GPB5 in the Adult Mosquito Aedes aegypti.

Authors:  David A Rocco; Jean-Paul V Paluzzi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-31       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.